{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T02:04:49Z","timestamp":1790906689141,"version":"4.1.0"},"reference-count":69,"publisher":"MDPI AG","issue":"3","license":[{"start":{"date-parts":[[2025,3,14]],"date-time":"2025-03-14T00:00:00Z","timestamp":1741910400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Development of a vaccine against coronavirus infection COVID-19","award":["IRN No.64356\/PTsF-MON-RK-OT-20"],"award-info":[{"award-number":["IRN No.64356\/PTsF-MON-RK-OT-20"]}]},{"name":"Science Committee of the Ministry of Education and Science of the Republic of Kazakhstan","award":["IRN No.64356\/PTsF-MON-RK-OT-20"],"award-info":[{"award-number":["IRN No.64356\/PTsF-MON-RK-OT-20"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Viruses"],"abstract":"<jats:p>Prompt determination of the etiological agent is important in an outbreak of pathogens with pandemic potential, particularly for dangerous infectious diseases. Molecular genetic methods allow for arriving at an accurate diagnosis, employing timely preventive measures, and controlling the spread of the disease-causing agent. In this study, whole-genome sequencing of three SARS-CoV-2 strains was performed using the Sanger method, which provides high accuracy in determining nucleotide sequences and avoids errors associated with multiple DNA amplification. Complete nucleotide sequences of samples, KAZ\/Britain\/2021, KAZ\/B1.1\/2021, and KAZ\/Delta020\/2021 were obtained, with sizes of 29.751 bp, 29.815 bp, and 29.840 bp, respectively. According to the COVID-19 Genome Annotator, 127 mutations were detected in the studied samples compared to the reference strain. The strain KAZ\/Britain\/2021 contained 3 deletions, 7 synonymous mutations, and 27 non-synonymous mutations, the second strain KAZ\/B1.1\/2021 contained 1 deletion, 5 synonymous mutations, and 31 non-synonymous mutations, and the third strain KAZ\/Delta020\/2021 contained 1 deletion, 5 synonymous mutations, and 37 non-synonymous mutations, respectively. The variations C241T, F106F, P314L, and D614G found in the 5\u2032 UTR, ORF1ab, and S regions were common to all three studied samples, respectively. According to PROVEAN data, the loss-of-function mutations identified in strains KAZ\/Britain\/2021, KAZ\/B1.1\/2021, and KAZ\/Delta020\/2021 include 5 mutations (P218L, T716I, W149L, R52I, and Y73C), 2 mutations (S813I and Q992H), and 8 mutations (P77L, L452R, I82T, P45L, V82A, F120L, F120L, and R203M), respectively. Phylogenetic analysis showed that the strains studied (KAZ\/Britain\/2021, KAZ\/B1.1\/2021, and KAZ\/Delta020\/2021) belong to different SARS-CoV-2 lineages, which are closely related to samples from Germany (OU141323.1 and OU365922.1), Mexico (OK432605.1), and again Germany (OV375251.1 and OU375174.1), respectively. The nucleotide sequences of the studied SARS-CoV-2 virus strains were registered in the Genbank database with the accession numbers: ON692539.1, OP684305, and OQ561548.1.<\/jats:p>","DOI":"10.3390\/v17030415","type":"journal-article","created":{"date-parts":[[2025,3,14]],"date-time":"2025-03-14T07:02:16Z","timestamp":1741935736000},"page":"415","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Genetic Variations of Three Kazakhstan Strains of the SARS-CoV-2 Virus"],"prefix":"10.3390","volume":"17","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4615-1328","authenticated-orcid":false,"given":"Bekbolat","family":"Usserbayev","sequence":"first","affiliation":[{"name":"Research Institute for Biological Safety Problems, National Holding QazBioPharm, LLP, Guardeyskiy uts 080409, Kazakhstan"},{"name":"Institute of Biotechnology, National Academy of Science of Kyrgyzstan, Bishkek 720071, Kyrgyzstan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kulyaisan","family":"Sultankulova","sequence":"additional","affiliation":[{"name":"Research Institute for Biological Safety Problems, National Holding QazBioPharm, LLP, Guardeyskiy uts 080409, Kazakhstan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4701-1992","authenticated-orcid":false,"given":"Yerbol","family":"Burashev","sequence":"additional","affiliation":[{"name":"Research Institute for Biological Safety Problems, National Holding QazBioPharm, LLP, Guardeyskiy uts 080409, Kazakhstan"},{"name":"Scientific Research Institute of Biology and Biotechnology Problems, al-Farabi Kazakh National University, Almaty 050040, Kazakhstan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aibarys","family":"Melisbek","sequence":"additional","affiliation":[{"name":"Research Institute for Biological Safety Problems, National Holding QazBioPharm, LLP, Guardeyskiy uts 080409, Kazakhstan"},{"name":"Scientific Research Institute of Biology and Biotechnology Problems, al-Farabi Kazakh National University, Almaty 050040, Kazakhstan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meirzhan","family":"Shirinbekov","sequence":"additional","affiliation":[{"name":"Research Institute for Biological Safety Problems, National Holding QazBioPharm, LLP, Guardeyskiy uts 080409, Kazakhstan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Balzhan","family":"Myrzakhmetova","sequence":"additional","affiliation":[{"name":"Research Institute for Biological Safety Problems, National Holding QazBioPharm, LLP, Guardeyskiy uts 080409, Kazakhstan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Asankadir","family":"Zhunushov","sequence":"additional","affiliation":[{"name":"Institute of Biotechnology, National Academy of Science of Kyrgyzstan, Bishkek 720071, Kyrgyzstan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Izat","family":"Smekenov","sequence":"additional","affiliation":[{"name":"Scientific Research Institute of Biology and Biotechnology Problems, al-Farabi Kazakh National University, Almaty 050040, Kazakhstan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aslan","family":"Kerimbaev","sequence":"additional","affiliation":[{"name":"Research Institute for Biological Safety Problems, National Holding QazBioPharm, LLP, Guardeyskiy uts 080409, Kazakhstan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sergazy","family":"Nurabaev","sequence":"additional","affiliation":[{"name":"Research Institute for Biological Safety Problems, National Holding QazBioPharm, LLP, Guardeyskiy uts 080409, Kazakhstan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7954-6246","authenticated-orcid":false,"given":"Olga","family":"Chervyakova","sequence":"additional","affiliation":[{"name":"Research Institute for Biological Safety Problems, National Holding QazBioPharm, LLP, Guardeyskiy uts 080409, Kazakhstan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6299-9399","authenticated-orcid":false,"given":"Nurlan","family":"Kozhabergenov","sequence":"additional","affiliation":[{"name":"Research Institute for Biological Safety Problems, National Holding QazBioPharm, LLP, Guardeyskiy uts 080409, Kazakhstan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lesbek","family":"Kutumbetov","sequence":"additional","affiliation":[{"name":"Research Institute for Biological Safety Problems, National Holding QazBioPharm, LLP, Guardeyskiy uts 080409, Kazakhstan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2025,3,14]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.jare.2020.03.005","article-title":"COVID-19 infection: Origin, transmission, and characteristics of human coronaviruses","volume":"24","author":"Shereen","year":"2020","journal-title":"J. Adv. Res."},{"key":"ref_2","unstructured":"World Health Organization (2025, March 06). COVID-19 Dashboard. Available online: https:\/\/covid19.who.int\/."},{"key":"ref_3","doi-asserted-by":"crossref","unstructured":"Zhugunissov, K., Zakarya, K., Khairullin, B., Orynbayev, M., Abduraimov, Y., Kassenov, M., Sultankulova, K., Kerimbayev, A., Nurabayev, S., and Myrzakhmetova, B. (2021). Development of the Inactivated QazCovid-in Vaccine: Protective Efficacy of the Vaccine in Syrian Hamsters. Front. Microbiol., 12.","DOI":"10.3389\/fmicb.2021.720437"},{"key":"ref_4","doi-asserted-by":"crossref","unstructured":"Usserbayev, B., Zakarya, K., Kutumbetov, L., Orynbayev, M., Sultankulova, K., Abduraimov, Y., Myrzakhmetova, B., Zhugunissov, K., Kerimbayev, A., and Melisbek, A. (2022). Near-complete genome sequence of a SARS-CoV-2 variant B. 1.1. 7 virus strain isolated in Kazakhstan. Microbiol. Resour. Announc., 11.","DOI":"10.1128\/mra.00619-22"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1056\/NEJMoa2001017","article-title":"A novel coronavirus from patients with pneumonia in China, 2019","volume":"382","author":"Zhu","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1038\/s41586-020-2008-3","article-title":"A new coronavirus associated with human respiratory disease in China","volume":"579","author":"Wu","year":"2020","journal-title":"Nature"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.cytogfr.2021.06.001","article-title":"SARS-CoV-2 Mutations and their Viral Variants","volume":"63","author":"Cosar","year":"2022","journal-title":"Cytokine Growth Factor. Rev."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1007\/s00705-021-05295-5","article-title":"Evolution of the SARS-CoV-2 genome and emergence of variants of concern","volume":"167","author":"Safari","year":"2022","journal-title":"Arch. Virol."},{"key":"ref_9","doi-asserted-by":"crossref","unstructured":"Andre, M., Lau, L.S., Pokharel, M.D., Ramelow, J., Owens, F., Souchak, J., Akkaoui, J., Ales, E., Brown, H., and Shil, R. (2023). From alpha to omicron: How different variants of concern of the SARS-Coronavirus-2 impacted the world. Biology, 12.","DOI":"10.3390\/biology12091267"},{"key":"ref_10","first-page":"451","article-title":"Genomic evolution of the SARS-CoV-2 Variants of Concern: COVID-19 pandemic waves in India","volume":"22","author":"Bhardwaj","year":"2023","journal-title":"EXCLI J."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"e246","DOI":"10.1017\/S095026882100220X","article-title":"First whole-genome analysis of the novel coronavirus (SARS-CoV-2) obtained from COVID-19 patients from five districts in Western Serbia","volume":"149","author":"Volkening","year":"2021","journal-title":"Epidemiol Infect"},{"key":"ref_12","doi-asserted-by":"crossref","unstructured":"Mercatelli, D., and Giorgi, F.M. (2020). Geographic and Genomic Distribution of SARS-CoV-2 Mutations. Front. Microbiol., 11.","DOI":"10.3389\/fmicb.2020.01800"},{"key":"ref_13","doi-asserted-by":"crossref","unstructured":"LaTourrette, K., and Garcia-Ruiz, H. (2022). Determinants of Virus Variation, Evolution, and Host Adaptation. Pathogens, 11.","DOI":"10.3390\/pathogens11091039"},{"key":"ref_14","doi-asserted-by":"crossref","unstructured":"M\u00e1rquez, S., Prado-Vivar, B., Guadalupe, J.J., Gutierrez, B., Jibaja, M., Tobar, M., Mora, F., Gaviria, J., Garc\u00eda, M., and Espinosa, F. (2020). Genome sequencing of the first SARS-CoV-2 reported from patients with COVID-19 in Ecuador. medRxiv.","DOI":"10.1101\/2020.06.11.20128330"},{"key":"ref_15","doi-asserted-by":"crossref","unstructured":"Mohammadi, E., Shafiee, F., Shahzamani, K., Ranjbar, M.M., Alibakhshi, A., Ahangarzadeh, S., Beikmohammadi, L., Shariati, L., Hooshmandi, S., and Ataei, B. (2021). Novel and emerging mutations of SARS-CoV-2: Biomedical implications. Biomed. Pharmacother., 139.","DOI":"10.1016\/j.biopha.2021.111599"},{"key":"ref_16","unstructured":"National Center for Biotechnology Information (NCBI) (2025, March 06). SARS-CoV-2 Reference Genome, Available online: https:\/\/www.ncbi.nlm.nih.gov\/nuccore\/NC_045512.2."},{"key":"ref_17","unstructured":"National Center for Biotechnology Information (NCBI) (2025, March 06). BLAST: Basic Local Alignment Search Tool, Available online: https:\/\/blast.ncbi.nlm.nih.gov\/Blast.cgi."},{"key":"ref_18","unstructured":"Burashev, Y. (2025, March 06). Primers for Whole Genome Sequencing of the Sars-Cov-2 Virus. Zenodo. Available online: https:\/\/zenodo.org\/records\/7264509."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"veab064","DOI":"10.1093\/ve\/veab064","article-title":"Assignment of epidemiological lineages in an emerging pandemic using the pangolin tool","volume":"7","author":"Scher","year":"2021","journal-title":"Virus Evol."},{"key":"ref_20","unstructured":"(2025, March 06). COVID-19 genome annotator. Available online: http:\/\/giorgilab.unibo.it\/coronannotator\/."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"2745","DOI":"10.1093\/bioinformatics\/btv195","article-title":"PROVEAN web server: A tool to predict the functional effect of amino acid substitutions and indels","volume":"31","author":"Choi","year":"2015","journal-title":"Bioinformatics"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"3022","DOI":"10.1093\/molbev\/msab120","article-title":"MEGA 11: Molecular Evolutionary Genetics Analysis Version 11","volume":"38","author":"Tamura","year":"2021","journal-title":"Mol. Biol. Evol."},{"key":"ref_23","first-page":"406","article-title":"The neighbor-joining method: A new method for reconstructing phylogenetic trees","volume":"4","author":"Saitou","year":"1987","journal-title":"Mol. Biol. Evol."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"783","DOI":"10.2307\/2408678","article-title":"Confidence limits on phylogenies: An approach using the bootstrap","volume":"39","author":"Felsenstein","year":"1985","journal-title":"Evolution"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"11030","DOI":"10.1073\/pnas.0404206101","article-title":"Prospects for inferring very large phylogenies by using the neighbor-joining method","volume":"101","author":"Tamura","year":"2004","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_26","doi-asserted-by":"crossref","unstructured":"Burashev, Y., Usserbayev, B., Kutumbetov, L., Abduraimov, Y., Kassenov, M., Kerimbayev, A., Myrzakhmetova, B., Melisbek, A., Shirinbekov, M., and Khaidarov, S. (2022). Coding Complete Genome Sequence of the SARS-CoV-2 Virus Strain, Variant B.1.1, Sampled from Kazakhstan. Microbiol. Resour. Announc., 11.","DOI":"10.1128\/mra.01114-22"},{"key":"ref_27","doi-asserted-by":"crossref","unstructured":"Usserbayev, B., Abduraimov, Y., Kozhabergenov, N., Melisbek, A., Shirinbekov, M., Smagul, M., Nusupbayeva, G., Nakhanov, A., and Burashev, Y. (2023). Complete Coding Sequence of a Lineage AY.122 SARS-CoV-2 Virus Strain Detected in Kazakhstan. Microbiol. Resour. Announc., 12.","DOI":"10.1128\/mra.00301-23"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"5189","DOI":"10.1002\/jmv.27964","article-title":"Temporal changes in the accessory protein mutations of SARS-CoV-2 variants and their predicted structural and functional effects","volume":"94","author":"Cruz","year":"2022","journal-title":"J. Med. Virol."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1098\/rstb.2001.0889","article-title":"Diseases of humans and their domestic mammals: Pathogen characteristics, host range and the risk of emergence","volume":"356","author":"Cleaveland","year":"2001","journal-title":"Philos. Trans. R. Soc. Lond. B Biol. Sci."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"245","DOI":"10.2217\/fvl-2020-0204","article-title":"Comparative sequence analysis of SARS-CoV-2 suggests its high transmissibility and pathogenicity","volume":"16","author":"Padhan","year":"2021","journal-title":"Future Virol."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1159\/000478729","article-title":"Evolution and Emergence of Pathogenic Viruses: Past, Present, and Future","volume":"60","author":"Parvez","year":"2017","journal-title":"Intervirology"},{"key":"ref_32","doi-asserted-by":"crossref","unstructured":"Lee, S.H. (2021). A Routine Sanger Sequencing Target Specific Mutation Assay for SARS-CoV-2 Variants of Concern and Interest. Viruses, 13.","DOI":"10.20944\/preprints202109.0415.v1"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1002\/jmv.25701","article-title":"Transmission dynamics and evolutionary history of 2019-nCoV","volume":"92","author":"Li","year":"2020","journal-title":"J Med Virol"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1038\/s41423-020-00523-5","article-title":"Linear epitopes of SARS-CoV-2 spike protein elicit neutralizing antibodies in COVID-19 patients","volume":"17","author":"Li","year":"2020","journal-title":"Cell Mol. Immunol."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1186\/s12967-023-03996-w","article-title":"Global landscape of SARS-CoV-2 mutations and conserved regions","volume":"21","author":"Abbasian","year":"2023","journal-title":"J. Transl. Med."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1038\/s41579-021-00573-0","article-title":"SARS-CoV-2 variants, spike mutations and immune escape","volume":"19","author":"Harvey","year":"2021","journal-title":"Nat. Rev. Microbiol."},{"key":"ref_37","doi-asserted-by":"crossref","unstructured":"Esman, A., Dubodelov, D., Khafizov, K., Kotov, I., Roev, G., Golubeva, A., Gasanov, G., Korabelnikova, M., Turashev, A., and Cherkashin, E. (2023). Development and Application of Real-Time PCR-Based Screening for Identification of Omicron SARS-CoV-2 Variant Sublineages. Genes, 14.","DOI":"10.3390\/genes14061218"},{"key":"ref_38","first-page":"000774","article-title":"Targeted Sanger sequencing to recover key mutations in SARS-CoV-2 variant genome assemblies produced by next-generation sequencing","volume":"8","author":"Singh","year":"2022","journal-title":"Microb. Genom."},{"key":"ref_39","unstructured":"World Health Organization (2021). Genomic Sequencing of SARS-CoV-2: A Guide to Implementation for Maximum Impact on Public Health, World Health Organization."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"2201","DOI":"10.1016\/j.cell.2021.02.033","article-title":"Reduced neutralization of SARS-CoV-2 B.1.1.7 variant by convalescent and vaccine sera","volume":"184","author":"Supasa","year":"2021","journal-title":"Cell"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"104971","DOI":"10.1016\/j.meegid.2021.104971","article-title":"Recent progress on the mutations of SARS-CoV-2 spike protein and suggestions for prevention and controlling of the pandemic","volume":"93","author":"Li","year":"2021","journal-title":"Infect. Genet. Evol."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"e110","DOI":"10.1017\/S0950268821001060","article-title":"SARS-CoV-2 mutations: The biological trackway towards viral fitness","volume":"149","author":"Majumdar","year":"2021","journal-title":"Epidemiol. Infect."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"109292","DOI":"10.1016\/j.celrep.2021.109292","article-title":"Recurrent emergence of SARS-CoV-2 spike deletion H69\/V70 and its role in the Alpha variant B.1.1.7","volume":"35","author":"Meng","year":"2021","journal-title":"Cell Rep."},{"key":"ref_44","doi-asserted-by":"crossref","unstructured":"Weng, S., Zhou, H., Ji, C., Li, L., Han, N., Yang, R., Shang, J., and Wu, A. (2022). Conserved Pattern and Potential Role of Recurrent Deletions in SARS-CoV-2 Evolution. Microbiol. Spectr., 10.","DOI":"10.1128\/spectrum.02191-21"},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1126\/science.abf6950","article-title":"Recurrent deletions in the SARS-CoV-2 spike glycoprotein drive antibody escape","volume":"371","author":"McCarthy","year":"2021","journal-title":"Science"},{"key":"ref_46","unstructured":"Davies, N.G., Abbott, S., Barnard, R.C., Jarvis, C.I., Kucharski, A.J., Munday, J., Pearson, C.A., Russell, T.W., Tully, D.C., and Washburne, A.D. (2020). Estimated transmissibility and severity of novel SARS-CoV-2 variant of concern 202012\/01 in England. medRxiv."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1016\/j.chom.2021.04.005","article-title":"A combination of cross-neutralizing antibodies synergizes to prevent SARS-CoV-2 and SARS-CoV pseudovirus infection","volume":"29","author":"Liu","year":"2021","journal-title":"Cell Host Microbe"},{"key":"ref_48","doi-asserted-by":"crossref","unstructured":"Khetran, S.R., and Mustafa, R. (2023). Mutations of SARS-CoV-2 Structural Proteins in the Alpha, Beta, Gamma, and Delta Variants: Bioinformatics Analysis. JMIR Bioinform. Biotech., 4.","DOI":"10.2196\/43906"},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1038\/s41586-020-2012-7","article-title":"A pneumonia outbreak associated with a new coronavirus of probable bat origin","volume":"579","author":"Zhou","year":"2020","journal-title":"Nature"},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1016\/j.cell.2020.06.043","article-title":"Tracking Changes in SARS-CoV-2 Spike: Evidence that D614G Increases Infectivity of the COVID-19 Virus","volume":"182","author":"Korber","year":"2020","journal-title":"Cell"},{"key":"ref_51","doi-asserted-by":"crossref","unstructured":"Lubinski, B., Fernandes, M.H.V., Frazier, L., Tang, T., Daniel, S., Diel, D.G., Jaimes, J.A., and Whittaker, G.R. (2021). Functional evaluation of the P681H mutation on the proteolytic activation the SARS-CoV-2 variant B.1.1.7 (Alpha) spike. bioRxiv.","DOI":"10.1101\/2021.04.06.438731"},{"key":"ref_52","unstructured":"(2025, March 06). SARS-CoV-2 Lineage Tree. Available online: https:\/\/observablehq.com\/embed\/6475ff63fc3ebfb3."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1038\/s41564-020-0770-5","article-title":"A dynamic nomenclature proposal for SARS-CoV-2 lineages to assist genomic epidemiology","volume":"5","author":"Rambaut","year":"2020","journal-title":"Nat. Microbiol."},{"key":"ref_54","doi-asserted-by":"crossref","unstructured":"O\u2019Toole, \u00c1., Pybus, O.G., Abram, M.E., Kelly, E.J., and Rambaut, A. (2022). Pango lineage designation and assignment using SARS-CoV-2 spike gene nucleotide sequences. BMC Genom., 23.","DOI":"10.1186\/s12864-022-08358-2"},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"2068883","DOI":"10.1080\/21645515.2022.2068883","article-title":"Delta variant (B.1.617.2) of SARS-CoV-2: Mutations, impact, challenges and possible solutions","volume":"18","author":"Dhawan","year":"2022","journal-title":"Hum. Vaccin. Immunother."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1515\/jbcpp-2021-0251","article-title":"The \u201cDelta Plus\u201d COVID-19 variant has evolved to become the next potential variant of concern: Mutation history and measures of prevention","volume":"33","author":"Rahman","year":"2021","journal-title":"J. Basic. Clin. Physiol. Pharmacol."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"1641","DOI":"10.1002\/jmv.27526","article-title":"Omicron and Delta variant of SARS-CoV-2: A comparative computational study of spike protein","volume":"94","author":"Kumar","year":"2022","journal-title":"J. Med. Virol."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1038\/s41586-021-03777-9","article-title":"Reduced sensitivity of SARS-CoV-2 variant Delta to antibody neutralization","volume":"596","author":"Planas","year":"2021","journal-title":"Nature"},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1038\/s41586-021-03944-y","article-title":"SARS-CoV-2 B.1.617.2 delta variant replication and immune evasion","volume":"599","author":"Mlcochova","year":"2021","journal-title":"Nature"},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1186\/s12985-022-01951-7","article-title":"Mutations in SARS-CoV-2 structural proteins: A global analysis","volume":"19","author":"Abavisani","year":"2022","journal-title":"Virol. J."},{"key":"ref_61","doi-asserted-by":"crossref","unstructured":"Periwal, N., Rathod, S.B., Sarma, S., Johar, G.S., Jain, A., Barnwal, R.P., Srivastava, K.R., Kaur, B., Arora, P., and Sood, V. (2022). Time Series Analysis of SARS-CoV-2 Genomes and Correlations among Highly Prevalent Mutations. Microbiol. Spectr., 10.","DOI":"10.1128\/spectrum.01219-22"},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1016\/j.cell.2020.04.011","article-title":"The Architecture of SARS-CoV-2 Transcriptome","volume":"181","author":"Kim","year":"2020","journal-title":"Cell"},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"100798","DOI":"10.1016\/j.imu.2021.100798","article-title":"Genome-wide identification and prediction of SARS-CoV-2 mutations show an abundance of variants: Integrated study of bioinformatics and deep neural learning","volume":"27","author":"Hossain","year":"2021","journal-title":"Inform. Med. Unlocked"},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.antiviral.2013.11.006","article-title":"SARS-CoV ORF1b-encoded nonstructural proteins 12-16: Replicative enzymes as antiviral targets","volume":"101","author":"Subissi","year":"2014","journal-title":"Antiviral Res."},{"key":"ref_65","doi-asserted-by":"crossref","unstructured":"Haddad, D., John, S.E., Mohammad, A., Hammad, M.M., Hebbar, P., Channanath, A., Nizam, R., Al-Qabandi, S., Al Madhoun, A., and Alshukry, A. (2021). SARS-CoV-2: Possible recombination and emergence of potentially more virulent strains. PLoS ONE, 16.","DOI":"10.1371\/journal.pone.0251368"},{"key":"ref_66","doi-asserted-by":"crossref","unstructured":"Archana, A., Long, C., and Chandran, K. (2022). Analysis of SARS-CoV-2 amino acid mutations in New York City Metropolitan wastewater (2020\u20132022) reveals multiple traits with human health implications across the genome and environment-specific distinctions. medRxiv.","DOI":"10.1101\/2022.07.15.22277689"},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1126\/science.abb7498","article-title":"Structure of the RNA-dependent RNA polymerase from COVID-19 virus","volume":"368","author":"Gao","year":"2020","journal-title":"Science"},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1093\/infdis\/jiab368","article-title":"SARS-CoV-2 B.1.617 Mutations L452R and E484Q Are Not Synergistic for Antibody Evasion","volume":"224","author":"Ferreira","year":"2021","journal-title":"J. Infect. Dis."},{"key":"ref_69","unstructured":"Sharma, M. (2025, March 06). New \u2018Delta Plus\u2019 Variant of SARS-CoV-2 Identified; Here\u2019s What We Know So Far. India Toda, Available online: https:\/\/www.indiatoday.in\/coronavirus-outbreak\/story\/delta-plus-variant-covid-corona-coronavirus-sarscov2-1814768-2021-06-14."}],"container-title":["Viruses"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1999-4915\/17\/3\/415\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T16:53:33Z","timestamp":1760028813000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1999-4915\/17\/3\/415"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,14]]},"references-count":69,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2025,3]]}},"alternative-id":["v17030415"],"URL":"https:\/\/doi.org\/10.3390\/v17030415","relation":{},"ISSN":["1999-4915"],"issn-type":[{"value":"1999-4915","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3,14]]}}}